Anticancer Treatment Goals and Prognostic Misperceptions among Advanced Cancer Outpatients

被引:6
|
作者
Paiva, Carlos Eduardo [1 ,2 ,3 ]
Teixeira, Ana Clara [1 ]
Minto Lourenco, Bruna [1 ]
Preto, Daniel D'Almeida [1 ,2 ]
Valentino, Talita Caroline de Oliveira [1 ]
Mingardi, Mirella [1 ]
Paiva, Bianca Sakamoto Ribeiro [1 ,3 ]
机构
[1] Barretos Canc Hosp, Postgrad Program, Palliat Care & Qual Life Res Grp, BR-14784400 Barretos, SP, Brazil
[2] Barretos Canc Hosp, Dept Clin Oncol, BR-14784400 Barretos, SP, Brazil
[3] Barretos Canc Hosp, Learning & Res Inst, Researcher Support Ctr, BR-14784400 Barretos, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
cancer; prognostic markers; palliative care; perception of curability; communication; OF-LIFE CARE; PALLIATIVE CARE; PATIENTS PERCEPTIONS; DECISION-MAKING; MEDICAL-CARE; PATIENT; PREFERENCES; COMMUNICATION; ASSOCIATIONS; ATTITUDES;
D O I
10.3390/ijerph19106272
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
(1) Background: In the context of cancer incurability, the communication processes involving clinicians and patients with cancer are frequently complex. (2) Methods: A cross-sectional study that investigated outpatients with advanced cancers and their oncologists. Both were interviewed immediately after a medical appointment in which there was disease progression and/or clinical deterioration, and were asked about the patient's chance of curability and the goals of the prescribed cancer treatment. The patients were asked whether they would like to receive information about prognosis and how they would like to receive it. The analyses of agreement on perceptions were performed using the Kappa's test. (3) Results: the sample consisted of 90 patients and 28 oncologists. Seventy-eight (87.6%) patients answered that they wanted their oncologist to inform them about their prognosis; only 35.2% (n = 31) of them said they received such information at their present appointment. Regarding how they would prefer prognostic disclosure, 61.8% (n = 55) mentioned that the oncologist should consider ways to keep the patient's hope up; 73% (n = 65) of the patients reported odds >50% of cure. The agreement between oncologists' and their patients' perceptions regarding the treatment goals and curability was slight (k = 0.024 and k = 0.017, respectively). (4) Conclusions: The perceptions of patients and their oncologists regarding the goals of treatment and their chances of cure were in disagreement. New approaches are needed to improve the communication process between oncologists and patients with advanced cancer.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Decisional control preferences among patients with advanced cancer: An international multicenter cross-sectional survey
    Yennurajalingam, Sriram
    Rodrigues, Luis Fernando
    Shamieh, Omar M.
    Tricou, Colombe
    Filbet, Marilene
    Naing, Kyaw
    Ramaswamy, Akhileshwaran
    Perez-Cruz, Pedro Emilio
    Bautista, Mary Jocylyn S.
    Bunge, Sofia
    Muckaden, Mary Ann
    Fakrooden, Sarah
    Sewram, Vikash
    Tejedor, Antonio Noguera
    Rao, Shobha S.
    Williams, Janet L.
    Liu, Diane D.
    Park, Minjeong
    Lu, Zhanni
    Cantu, Hilda
    Hui, David
    Reddy, Suresh K.
    Bruera, Eduardo
    PALLIATIVE MEDICINE, 2018, 32 (04) : 870 - 880
  • [32] The Impacts of Prognostic Awareness on Mood and Quality of Life Among Patients With Advanced Cancer
    Kang, EunKyo
    Kang, Jung Hun
    Koh, Su-Jin
    Song, Eun-Kee
    Shim, Hyun-Jeong
    Keam, Bhumsuk
    Maeng, Chi-Hoon
    Kim, Yu Jung
    Yun, Hwan Jung
    Jung, Kyung Hae
    Kwon, Jung Hye
    Lee, Soon Nam
    Lee, Jung Lim
    Do, Young Rok
    Min, JeongHee
    Lee, Jihye
    Choo, Jiyeon
    Yun, Young Ho
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2020, 37 (11) : 904 - 912
  • [33] Associations Among Prognostic Understanding, Quality of Life, and Mood in Patients With Advanced Cancer
    El-Jawahri, Areej
    Traeger, Lara
    Park, Elyse R.
    Greer, Joseph A.
    Pirl, William F.
    Lennes, Inga T.
    Jackson, Vicki A.
    Gallagher, Emily R.
    Temel, Jennifer S.
    CANCER, 2014, 120 (02) : 278 - 285
  • [34] Clinicians' and Advanced Cancer Patients' Estimates of Treatment Efficacy and Toxicity in Oncologic Treatment
    Lee, Eun Mi
    Jimenez-Fonseca, Paula
    Carmona-Bayonas, Alberto
    Hernandez, Raquel
    Cruz-Castellanos, Patricia
    Obispo, Berta
    Antonanzas-Basa, Monica
    Palacin-Lois, Maria
    Castillo-Trujillo, Oscar A.
    Calderon, Caterina
    HEALTHCARE, 2023, 11 (15)
  • [35] Prognostic awareness in advanced cancer: an integrative literature review
    Mone, Sara
    Kerr, Helen
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2021, 11 (01) : 53 - 58
  • [36] The focus on life-prolonging anticancer treatment hampers shared decision-making in people with advanced cancer: A qualitative embedded multiple-case study
    Ermers, Daisy J. M.
    van Geel, Maartje J.
    Engels, Yvonne
    Kellenaers, Demi
    Schuurmans, Anouk S. J.
    van Amstel, Floortje K. Ploos
    van Herpen, Carla M. L.
    Schoon, Yvonne
    Schers, Henk J.
    Vissers, Kris C. P.
    Kuip, Evelien J. M.
    Perry, Marieke
    PALLIATIVE MEDICINE, 2024, 38 (10) : 1156 - 1168
  • [37] Advanced cancer patients' understanding of prognostic information: Applying insights from psychological research
    Derry, Heather M.
    Reid, M. Carrington
    Prigerson, Holly G.
    CANCER MEDICINE, 2019, 8 (09): : 4081 - 4088
  • [38] Distress Due to Prognostic Uncertainty in Palliative Care: Frequency, Distribution, and Outcomes among Hospitalized Patients with Advanced Cancer
    Gramling, Robert
    Stanek, Susan
    Han, Paul K. J.
    Duberstein, Paul
    Quill, Tim E.
    Temel, Jennifer S.
    Alexander, Stewart C.
    Anderson, Wendy G.
    Ladwig, Susan
    Norton, Sally A.
    JOURNAL OF PALLIATIVE MEDICINE, 2018, 21 (03) : 315 - 321
  • [39] Treatment with anticancer drugs for advanced pancreatic cancer: a systematic review
    Josefina Salazar
    Javier Bracchiglione
    Olga Savall-Esteve
    Alba Antequera
    David Bottaro-Parra
    Marta Gutiérrez-Valencia
    Susana Martínez-Peralta
    Carles Pericay
    Ariadna Tibau
    Xavier Bonfill
    BMC Cancer, 23
  • [40] Treatment with anticancer drugs for advanced pancreatic cancer: a systematic review
    Salazar, Josefina
    Bracchiglione, Javier
    Savall-Esteve, Olga
    Antequera, Alba
    Bottaro-Parra, David
    Gutierrez-Valencia, Marta
    Martinez-Peralta, Susana
    Pericay, Carles
    Tibau, Ariadna
    Bonfill, Xavier
    BMC CANCER, 2023, 23 (01)